Genetic Clinical Trials

240 recruitingLast updated: June 18, 2026

There are 240 actively recruiting genetic clinical trials across 49 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Early Phase 1, Phase 4. Top locations include Boston, Massachusetts, United States, New York, New York, United States, Philadelphia, Pennsylvania, United States. Updated daily from ClinicalTrials.gov.


Genetic Trials at a Glance

240 actively recruiting trials for genetic are listed on ClinicalTrialsFinder across 6 cities in 49 countries. The largest study group is Not Applicable with 67 trials, with the heaviest enrollment activity in Boston, New York, and Philadelphia. Lead sponsors running genetic studies include Centre Hospitalier Universitaire, Amiens, Columbia University, and Dana-Farber Cancer Institute.

Treatments under study

About Genetic Clinical Trials

Looking for clinical trials for Genetic? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Genetic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Genetic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 240 trials

Recruiting

Outcomes of Health Care Transition for AYA With a Cancer Predisposition

Genetic Predisposition
St. Jude Children's Research Hospital56 enrolled1 locationNCT07456904
Recruiting

Genetic, Microbiological and Behavioral Factors in Obesity

ObesityObesity, OverweightGenetics
Jan Kochanowski University200 enrolled2 locationsNCT07650149
Recruiting
Phase 2

Effects of Treatments on Atopic Dermatitis

DermatitisEczemaSkin Diseases+2 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)130 enrolled1 locationNCT01631617
Recruiting

Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics

Genetic diseasesFeverROSAH+4 more
National Human Genome Research Institute (NHGRI)5,000 enrolled5 locationsNCT00001373
Recruiting

Observational Study of Advanced Data Analytics in Genetic Conditions

genetic conditions
National Human Genome Research Institute (NHGRI)1,250 enrolled1 locationNCT05657405
Recruiting

Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network

Genetic Disease
National Human Genome Research Institute (NHGRI)20,000 enrolled33 locationsNCT02450851
Recruiting
Not Applicable

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

Scarring Alopeciaandrogenetic alopecia
Montefiore Medical Center10 enrolled1 locationNCT05460611
Recruiting

Vascular Disease Discovery Protocol

Vascular DysfunctionGenetic PredispositionGenetic Mutations
National Heart, Lung, and Blood Institute (NHLBI)1,000 enrolled1 locationNCT03538639
Recruiting

Genetics of Inherited Eye Disease

genetic eye disease
National Eye Institute (NEI)1,500 enrolled1 locationNCT02471287
Recruiting

Inherited Reproductive Disorders

InfertilityHypogonadismAmenorrhea+1 more
National Institute of Environmental Health Sciences (NIEHS)850 enrolled2 locationsNCT01500447
Recruiting

Rare Tumors and Cancer Predisposition in Individuals and Families

CancerGenetic Predisposition to CancerHereditary Neoplasms+1 more
National Cancer Institute (NCI)500 enrolled2 locationsNCT05350761
Recruiting
Not Applicable

Methylated Biomarkers of Smoking as a Selection Tool in Participants for Lung Cancer Screening

Lung Cancer ScreeningEpigeneticsDNA Methylation+2 more
University Hospital, Antwerp1,000 enrolled1 locationNCT07631624
Recruiting

Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes

GranulomaGranulomatous Disease, ChronicLeukocyte Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID)850 enrolled1 locationNCT00001405
Recruiting
Phase 2Phase 3

A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

Symptomatic Genetic Dilated Cardiomyopathy
Kardigan, Inc.332 enrolled43 locationsNCT07210723
Recruiting

UW Undiagnosed Genetic Diseases Program

Genetic DiseaseRare DiseasesUndiagnosed Disease
University of Wisconsin, Madison1,000 enrolled1 locationNCT04586075
Recruiting

guideSEQ: Genomic Understanding, Impact, Decision & Ethics in Prenatal Sequencing

Prenatal Genetic Diagnosis
Columbia University1,042 enrolled3 locationsNCT07610590
Recruiting

Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions

genetic eye disease
National Eye Institute (NEI)2,000 enrolled1 locationNCT02077894
Recruiting
Not Applicable

Evaluation of Optical Genome Mapping in Phi Negative Myeloproliferative Neoplasia in the Detection of Acquired Cytogenetic Abnormalities

Myeloproliferative NeoplasmPrognostic StratificationOptical Genome Mapping+2 more
Centre Hospitalier Universitaire, Amiens300 enrolled1 locationNCT05714592
Recruiting
Phase 1Phase 2

Study of EPI-001 in Patients With Androgenetic Alopecia

androgenetic alopecia
Epibiotech42 enrolled1 locationNCT07618195
Recruiting
Not Applicable

COsegregation of VARiants in Panel of Genes

Genetic PredispositionGene Mutation-Related Cancer
Institut Curie11,000 enrolled62 locationsNCT01689584